Article
Molecular analysis of an MHC class II deficiency patient reveals a novel mutation in the RFX5 gene.
Immunogenetics - 1 Apr 1999
Peijnenburg A, Van Eggermond M C, Van den Berg R, Sanal O, Vossen J M, Van den Elsen P J
Abstract excerpt
Patients suffering from major histocompatibility complex (MHC) class II deficiency, a rare primary immunodeficiency, are characterized by a lack of MHC class II expression which is the result of defects in trans-acting factors. At least four complementation groups, A, B, C, and D, can be discerned. The gene affected in group C patients is known to be RFX5 and encodes one of the subunits of the multimeric...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
